Obesity Trial, Recruiting NCT07662330 Sponsor: Shanghai 10th People's Hospital Condition: Obesity
Back to Obesity

Obesity Trial, Recruiting

NCT07662330
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People aged 18 to 65 years, of any sex
  • People with a body mass index (BMI) of 24 or higher, without serious long-term health conditions
  • People who are not currently taking medications to lower blood sugar or cholesterol
  • People with abnormal blood fat levels — specifically, triglycerides at or above 1.7 mmol/L, or total cholesterol at or above 5.2 mmol/L
  • People who have not been following an active weight loss or weight gain diet in the past month
  • People who have not made major changes to their eating pattern (such as keto, vegan, high-protein, meal replacement, or intermittent fasting diets) in the past month
  • People who have not been taking supplements that may affect polyamine intake (such as wheat germ, yeast, fermented extracts, or nutritional powders) in the past 2 to 4 weeks
  • People who are willing and able to sign a consent form agreeing to take part

Who may not be able to join:

  • People diagnosed with an acute or serious gut or digestive condition
  • People currently taking part in any other weight-loss program or therapy
  • People currently taking medications to lower blood sugar or cholesterol
  • People who have taken part in another clinical trial within the month before signing the consent form
  • People who are pregnant, breastfeeding, or planning to become pregnant during the trial
  • People with a known allergy to cellulose or wheat
  • People with a history of cancer
  • People with kidney problems, indicated by abnormal creatinine levels in the blood
  • People with liver problems, based on specific blood test results showing liver enzyme or bilirubin levels above a certain threshold (confirm with trial site)
  • People the trial doctor considers unsuitable for any other reason

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 20 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +86 17701621016

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Shanghai 10th People's Hospital
Registry
ClinicalTrials.gov
Start date
1 January 2026
Est. completion
31 December 2026

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Triglycerides (TG)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 20 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov